Our comprehensive pan-cancer analysis of HSP90B1 revealed that the high expression of HSP90B1 was associated with the poor clinical prognosis of various human cancers, indicating that HSP90B1 can be used as an effective biomarker in cancer. This evidence concerns the gene HSP90B1 and cancer.